Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice (Q45437157)

14 December 2017

title

Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice (English)

1 reference

14 December 2017

5

Antonin Holy

1 reference

14 December 2017

1

Donald F Smee

1 reference

14 December 2017

Miles K Wandersee

2

1 reference

14 December 2017

Kevin W Bailey

series ordinal

3

1 reference

14 December 2017

Karl Y Hostetler

series ordinal

4

1 reference

14 December 2017

Robert W Sidwell

series ordinal

6

1 reference

14 December 2017

language of work or name

1 reference

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

14 December 2017

published in

1 reference

14 December 2017

volume

16

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

203-211

1 reference

Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Infectious diseases. SARS researchers report new animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

A review of compounds exhibiting anti-orthopoxvirus activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/095632020501600306

10.1177/095632020501600306

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference